ArticleBMC endocrine disorders2026
Hyperinsulinemia and its associations with arterial stiffness and myocardial injury: a real-world cohort study.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyperinsulinemia is an early metabolic abnormality commonly associated with insulin resistance, but its relationship with cardiovascular injury in real-world populations remains incompletely understood. We examined whether fasting insulin is related to arterial stiffening and early myocardial biomarker abnormalities in a large health-examination population.
methodsThis real-world retrospective analysis enrolled 30,343 adults who received routine health examinations from January 2017 to November 2021. For individuals with multiple visits, the earliest examination was used as the baseline record. Fasting insulin was evaluated in quartile categories, a log-transformed continuous exposure, and a hyperinsulinemia indicator based on the cohort-specific 75th percentile. The binary arterial-stiffness endpoint was defined using a mean baPWV (brachial-ankle pulse wave velocity) threshold of 1400 cm/s or higher. Myocardial injury was evaluated by cardiac troponin I or T. Logistic regression models were fitted to quantify the relationships of fasting insulin and HOMA-IR (homeostatic model assessment of insulin resistance) with baPWV-related outcomes and myocardial injury markers. Dose-response patterns were explored using restricted cubic spline modeling. Subgroup analysis and sensitivity analysis were performed. Python (3.13.0) was used for statistical analysis.
resultsHigher insulin categories were accompanied by greater adiposity, blood pressure, glucose, HOMA-IR, triglycerides, baPWV, and arterial-stiffness. Hyperinsulinemia was correlated with arterial stiffness in the unadjusted model and adjusted model (OR, 1.31; 95% CI, 1.22-1.40, P < 0.001). Compared with the lowest insulin quartile, the highest quartile was associated with markedly increased odds of arterial stiffness (OR, 1.56; 95% CI, 1.41-1.74, P < 0.001). Spline curves indicated that fasting insulin and HOMA-IR were positively and non-linearly related to mean baPWV. In contrast, the association between hyperinsulinemia and composite myocardial injury was not statistically significant.
conclusionsIn this large real-world health examination cohort, hyperinsulinemia was independently and consistently associated with increased arterial stiffness. However, its association with subclinical myocardial injury was weaker. These results support fasting insulin as a potential early metabolic indicator of vascular stiffening, whereas its relationship with myocardial injury requires further longitudinal investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.